

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.35452013 |
| 2 | response to peptidoglycan (GO:0032494) | 5.08175483 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.05893793 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 5.05893793 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.05893793 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.05893793 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.05893793 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 5.05893793 |
| 9 | cellular ketone body metabolic process (GO:0046950) | 5.05344059 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.85382795 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.79405598 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.79405598 |
| 13 | L-phenylalanine catabolic process (GO:0006559) | 4.74455917 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.74455917 |
| 15 | L-phenylalanine metabolic process (GO:0006558) | 4.73108725 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.73108725 |
| 17 | complement activation, alternative pathway (GO:0006957) | 4.70721438 |
| 18 | kynurenine metabolic process (GO:0070189) | 4.64504995 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 4.59676052 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 4.58963783 |
| 21 | aromatic amino acid family catabolic process (GO:0009074) | 4.52626860 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 4.49598079 |
| 23 | negative regulation of interleukin-12 production (GO:0032695) | 4.45818329 |
| 24 | urea cycle (GO:0000050) | 4.43426498 |
| 25 | urea metabolic process (GO:0019627) | 4.43426498 |
| 26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.39450519 |
| 27 | alpha-linolenic acid metabolic process (GO:0036109) | 4.37928094 |
| 28 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.35354705 |
| 29 | regulation of protein activation cascade (GO:2000257) | 4.34067211 |
| 30 | tryptophan catabolic process (GO:0006569) | 4.33502701 |
| 31 | indole-containing compound catabolic process (GO:0042436) | 4.33502701 |
| 32 | indolalkylamine catabolic process (GO:0046218) | 4.33502701 |
| 33 | detection of other organism (GO:0098543) | 4.31360161 |
| 34 | protein carboxylation (GO:0018214) | 4.31080879 |
| 35 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.31080879 |
| 36 | neutrophil activation involved in immune response (GO:0002283) | 4.30395264 |
| 37 | ketone body metabolic process (GO:1902224) | 4.25690382 |
| 38 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.18400117 |
| 39 | regulation of cholesterol homeostasis (GO:2000188) | 4.12249741 |
| 40 | detection of bacterium (GO:0016045) | 4.11255038 |
| 41 | high-density lipoprotein particle remodeling (GO:0034375) | 4.09514726 |
| 42 | regulation of complement activation (GO:0030449) | 4.06964097 |
| 43 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.05630667 |
| 44 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.04462358 |
| 45 | tryptophan metabolic process (GO:0006568) | 4.03722135 |
| 46 | phospholipid efflux (GO:0033700) | 4.02245838 |
| 47 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.01466303 |
| 48 | nitrogen cycle metabolic process (GO:0071941) | 3.98723590 |
| 49 | regulation of fibrinolysis (GO:0051917) | 3.97577193 |
| 50 | response to muramyl dipeptide (GO:0032495) | 3.95343716 |
| 51 | homocysteine metabolic process (GO:0050667) | 3.94177539 |
| 52 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.90077174 |
| 53 | plasma lipoprotein particle clearance (GO:0034381) | 3.87742942 |
| 54 | detection of molecule of bacterial origin (GO:0032490) | 3.87273678 |
| 55 | germinal center formation (GO:0002467) | 3.82672720 |
| 56 | negative regulation of sterol transport (GO:0032372) | 3.81459313 |
| 57 | negative regulation of cholesterol transport (GO:0032375) | 3.81459313 |
| 58 | cellular extravasation (GO:0045123) | 3.78584866 |
| 59 | regulation of triglyceride catabolic process (GO:0010896) | 3.78113983 |
| 60 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.77510631 |
| 61 | detection of external biotic stimulus (GO:0098581) | 3.76176210 |
| 62 | glyoxylate metabolic process (GO:0046487) | 3.74970854 |
| 63 | cysteine metabolic process (GO:0006534) | 3.73919755 |
| 64 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.73880774 |
| 65 | immunoglobulin mediated immune response (GO:0016064) | 3.73302285 |
| 66 | acylglycerol homeostasis (GO:0055090) | 3.72804102 |
| 67 | triglyceride homeostasis (GO:0070328) | 3.72804102 |
| 68 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.72769394 |
| 69 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.71189633 |
| 70 | bile acid biosynthetic process (GO:0006699) | 3.69717492 |
| 71 | plasma lipoprotein particle assembly (GO:0034377) | 3.67690816 |
| 72 | regulation of gamma-delta T cell activation (GO:0046643) | 3.66209291 |
| 73 | cellular response to type I interferon (GO:0071357) | 3.59666125 |
| 74 | type I interferon signaling pathway (GO:0060337) | 3.59666125 |
| 75 | regulation of cholesterol esterification (GO:0010872) | 3.59199697 |
| 76 | reverse cholesterol transport (GO:0043691) | 3.59046033 |
| 77 | response to type I interferon (GO:0034340) | 3.56917689 |
| 78 | leukocyte aggregation (GO:0070486) | 3.54947545 |
| 79 | serine family amino acid catabolic process (GO:0009071) | 3.54766957 |
| 80 | NIK/NF-kappaB signaling (GO:0038061) | 3.51470026 |
| 81 | protein-lipid complex assembly (GO:0065005) | 3.49652754 |
| 82 | protein-lipid complex remodeling (GO:0034368) | 3.48459136 |
| 83 | macromolecular complex remodeling (GO:0034367) | 3.48459136 |
| 84 | plasma lipoprotein particle remodeling (GO:0034369) | 3.48459136 |
| 85 | glycine metabolic process (GO:0006544) | 3.47614523 |
| 86 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.45596974 |
| 87 | low-density lipoprotein particle clearance (GO:0034383) | 3.41440009 |
| 88 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.39174474 |
| 89 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.38756804 |
| 90 | response to host immune response (GO:0052572) | 3.37157821 |
| 91 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.37157821 |
| 92 | amino-acid betaine metabolic process (GO:0006577) | 3.36971461 |
| 93 | bile acid metabolic process (GO:0008206) | 3.35386047 |
| 94 | lysine metabolic process (GO:0006553) | 3.34279767 |
| 95 | lysine catabolic process (GO:0006554) | 3.34279767 |
| 96 | detection of biotic stimulus (GO:0009595) | 3.33155737 |
| 97 | granulocyte activation (GO:0036230) | 3.30849218 |
| 98 | cholesterol efflux (GO:0033344) | 3.28292926 |
| 99 | neutrophil activation (GO:0042119) | 3.26393063 |
| 100 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.25603144 |
| 101 | fibrinolysis (GO:0042730) | 3.24740974 |
| 102 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.24094866 |
| 103 | aromatic amino acid family metabolic process (GO:0009072) | 3.23009342 |
| 104 | acute-phase response (GO:0006953) | 3.22969637 |
| 105 | defense response to protozoan (GO:0042832) | 3.22259570 |
| 106 | response to host (GO:0075136) | 3.21538483 |
| 107 | response to host defenses (GO:0052200) | 3.21538483 |
| 108 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.21538483 |
| 109 | regulation of bile acid biosynthetic process (GO:0070857) | 3.21316559 |
| 110 | macrophage activation (GO:0042116) | 3.20544532 |
| 111 | valine metabolic process (GO:0006573) | 3.20055137 |
| 112 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.19932091 |
| 113 | regulation of mast cell degranulation (GO:0043304) | 3.19491410 |
| 114 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.18724349 |
| 115 | myeloid cell activation involved in immune response (GO:0002275) | 3.18180383 |
| 116 | positive regulation of lipid catabolic process (GO:0050996) | 3.18052918 |
| 117 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.15147571 |
| 118 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.14597294 |
| 119 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.12966906 |
| 120 | phospholipid homeostasis (GO:0055091) | 3.12670059 |
| 121 | regulation of interferon-alpha production (GO:0032647) | 3.12410201 |
| 122 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.11387260 |
| 123 | regulation of cholesterol storage (GO:0010885) | 3.10428467 |
| 124 | response to protozoan (GO:0001562) | 3.08910711 |
| 125 | positive regulation of interferon-alpha production (GO:0032727) | 3.06849755 |
| 126 | complement activation (GO:0006956) | 3.06804793 |
| 127 | cholesterol homeostasis (GO:0042632) | 3.06621385 |
| 128 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.06133426 |
| 129 | alpha-amino acid catabolic process (GO:1901606) | 3.04036131 |
| 130 | respiratory burst (GO:0045730) | 3.03710602 |
| 131 | complement activation, classical pathway (GO:0006958) | 3.02246062 |
| 132 | sterol homeostasis (GO:0055092) | 3.01707579 |
| 133 | response to growth hormone (GO:0060416) | 3.01672227 |
| 134 | bile acid and bile salt transport (GO:0015721) | 3.01173724 |
| 135 | T-helper 1 type immune response (GO:0042088) | 2.99750723 |
| 136 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.99549007 |
| 137 | negative regulation of T cell mediated immunity (GO:0002710) | 2.97219835 |
| 138 | plasma lipoprotein particle organization (GO:0071827) | 2.96943110 |
| 139 | protein activation cascade (GO:0072376) | 2.96272964 |
| 140 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.95699059 |
| 141 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.95699059 |
| 142 | regulation of leukocyte degranulation (GO:0043300) | 2.93584877 |
| 143 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.92358950 |
| 144 | myeloid dendritic cell differentiation (GO:0043011) | 2.92095126 |
| 145 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.91905318 |
| 146 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.91307167 |
| 147 | protein-lipid complex subunit organization (GO:0071825) | 2.91033765 |
| 148 | serine family amino acid metabolic process (GO:0009069) | 2.90904977 |
| 149 | positive regulation of type 2 immune response (GO:0002830) | 2.89162674 |
| 150 | ethanol oxidation (GO:0006069) | 2.89079236 |
| 151 | lipoprotein metabolic process (GO:0042157) | 2.88926079 |
| 152 | neutrophil mediated immunity (GO:0002446) | 2.88857164 |
| 153 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.87832145 |
| 154 | cellular zinc ion homeostasis (GO:0006882) | 2.87731431 |
| 155 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.87515671 |
| 156 | vitamin transmembrane transport (GO:0035461) | 2.87456465 |
| 157 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.86500683 |
| 158 | negative regulation of interleukin-6 production (GO:0032715) | 2.86370980 |
| 159 | microglial cell activation (GO:0001774) | 2.86232918 |
| 160 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.85563338 |
| 161 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.85533421 |
| 162 | indolalkylamine metabolic process (GO:0006586) | 2.83920045 |
| 163 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.83910842 |
| 164 | tyrosine metabolic process (GO:0006570) | 2.82895084 |
| 165 | serine family amino acid biosynthetic process (GO:0009070) | 2.81765993 |
| 166 | regulation of T cell tolerance induction (GO:0002664) | 2.81715974 |
| 167 | cellular amino acid catabolic process (GO:0009063) | 2.81320052 |
| 168 | pentose-phosphate shunt (GO:0006098) | 2.80991893 |
| 169 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.79343514 |
| 170 | B cell mediated immunity (GO:0019724) | 2.78419410 |
| 171 | cytolysis (GO:0019835) | 2.77171696 |
| 172 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.75973061 |
| 173 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.75860820 |
| 174 | T cell migration (GO:0072678) | 2.75187403 |
| 175 | intestinal cholesterol absorption (GO:0030299) | 2.74347408 |
| 176 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.74158018 |
| 177 | imidazole-containing compound metabolic process (GO:0052803) | 2.73471147 |
| 178 | response to interleukin-15 (GO:0070672) | 2.71791447 |
| 179 | coenzyme catabolic process (GO:0009109) | 2.71427153 |
| 180 | regulation of type 2 immune response (GO:0002828) | 2.70727151 |
| 181 | amine catabolic process (GO:0009310) | 2.69689889 |
| 182 | cellular biogenic amine catabolic process (GO:0042402) | 2.69689889 |
| 183 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.69269966 |
| 184 | negative regulation of lipid transport (GO:0032369) | 2.68895323 |
| 185 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.68278822 |
| 186 | negative regulation of innate immune response (GO:0045824) | 2.67980224 |
| 187 | myeloid dendritic cell activation (GO:0001773) | 2.67957614 |
| 188 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.66558216 |
| 189 | B cell receptor signaling pathway (GO:0050853) | 2.65367600 |
| 190 | regulation of tolerance induction (GO:0002643) | 2.64874836 |
| 191 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.63016636 |
| 192 | regulation of necroptotic process (GO:0060544) | 2.61689666 |
| 193 | regulation of antigen processing and presentation (GO:0002577) | 2.59975202 |
| 194 | tolerance induction (GO:0002507) | 2.59490363 |
| 195 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.59251034 |
| 196 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.58751388 |
| 197 | myeloid leukocyte activation (GO:0002274) | 2.58644802 |
| 198 | positive regulation of B cell differentiation (GO:0045579) | 2.57122879 |
| 199 | negative regulation of type 2 immune response (GO:0002829) | 2.56876960 |
| 200 | positive regulation of interferon-beta production (GO:0032728) | 2.56157385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.38149211 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.72045714 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.44728457 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.61566704 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.56696104 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.15692725 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.12265259 |
| 8 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.87231261 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.61777061 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.36808716 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.33732668 |
| 12 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.17780812 |
| 13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.16771905 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.13909771 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.08077460 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.06844969 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.06640299 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.05836773 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.05696400 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.05171587 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.01139484 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.99744587 |
| 23 | SPI1_23127762_ChIP-Seq_K562_Human | 1.97912117 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.90745883 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.90277610 |
| 26 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.89924257 |
| 27 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.87659017 |
| 28 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.87310988 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.83505338 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.81032589 |
| 31 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.78987164 |
| 32 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.72571812 |
| 33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.71510599 |
| 34 | MYB_26560356_Chip-Seq_TH2_Human | 1.71161042 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.68788487 |
| 36 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.68786596 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.68367110 |
| 38 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.62852225 |
| 39 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56308863 |
| 40 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.52977075 |
| 41 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.49545034 |
| 42 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.49175427 |
| 43 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.48596178 |
| 44 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.48332749 |
| 45 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.46870568 |
| 46 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.45203652 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.42804576 |
| 48 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.38164770 |
| 49 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.38161917 |
| 50 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.37206905 |
| 51 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.37181759 |
| 52 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.36751221 |
| 53 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34381463 |
| 54 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.33898322 |
| 55 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.31756256 |
| 56 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.31404621 |
| 57 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.29954399 |
| 58 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.29667208 |
| 59 | MAF_26560356_Chip-Seq_TH1_Human | 1.28434824 |
| 60 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.27409003 |
| 61 | UTX_26944678_Chip-Seq_JUKART_Human | 1.25588872 |
| 62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.25445388 |
| 63 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25199466 |
| 64 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.23868521 |
| 65 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23543382 |
| 66 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.23428331 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22756137 |
| 68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20190026 |
| 69 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.18237192 |
| 70 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.17480568 |
| 71 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16239588 |
| 72 | KDM2B_26808549_Chip-Seq_K562_Human | 1.15878002 |
| 73 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15755637 |
| 74 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15167666 |
| 75 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.15104107 |
| 76 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.14502596 |
| 77 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.14362632 |
| 78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14204666 |
| 79 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.13774261 |
| 80 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12713149 |
| 81 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12413581 |
| 82 | GATA1_22025678_ChIP-Seq_K562_Human | 1.11078908 |
| 83 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10113751 |
| 84 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09696923 |
| 85 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.08668927 |
| 86 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08186950 |
| 87 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07478391 |
| 88 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.07391229 |
| 89 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.07318073 |
| 90 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06118602 |
| 91 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05977418 |
| 92 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.04891928 |
| 93 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03450289 |
| 94 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03183510 |
| 95 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02992168 |
| 96 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.02654922 |
| 97 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01904204 |
| 98 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01810111 |
| 99 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.01505742 |
| 100 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01109733 |
| 101 | MAF_26560356_Chip-Seq_TH2_Human | 1.00649167 |
| 102 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.00323951 |
| 103 | MYB_26560356_Chip-Seq_TH1_Human | 1.00175433 |
| 104 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00146870 |
| 105 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99822075 |
| 106 | * P68_20966046_ChIP-Seq_HELA_Human | 0.99133500 |
| 107 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.97528998 |
| 108 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.94952654 |
| 109 | * VDR_24763502_ChIP-Seq_THP-1_Human | 0.94838698 |
| 110 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.94465868 |
| 111 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93962504 |
| 112 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.93663046 |
| 113 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93279685 |
| 114 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.92149346 |
| 115 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91956436 |
| 116 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.89689293 |
| 117 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89579334 |
| 118 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.89322921 |
| 119 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.88511941 |
| 120 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.88446153 |
| 121 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.88333573 |
| 122 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88288791 |
| 123 | * TFEB_21752829_ChIP-Seq_HELA_Human | 0.88285932 |
| 124 | * ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88259127 |
| 125 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.88094586 |
| 126 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.87868020 |
| 127 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.87581093 |
| 128 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87363890 |
| 129 | * CTCF_21964334_Chip-Seq_Bcells_Human | 0.87357029 |
| 130 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.86058804 |
| 131 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.85895409 |
| 132 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.85100901 |
| 133 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.85004559 |
| 134 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.84545180 |
| 135 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.83502068 |
| 136 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.83442326 |
| 137 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83282286 |
| 138 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.83081621 |
| 139 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.82669803 |
| 140 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82490431 |
| 141 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.82264471 |
| 142 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.82168299 |
| 143 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.82149259 |
| 144 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81911863 |
| 145 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.81762182 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.97887059 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.86943838 |
| 3 | MP0005365_abnormal_bile_salt | 4.18190565 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.84293687 |
| 5 | MP0009840_abnormal_foam_cell | 3.51977345 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.14070755 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.13898345 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 2.76769176 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.68143496 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.66044389 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.59065781 |
| 12 | MP0003252_abnormal_bile_duct | 2.48836025 |
| 13 | MP0005671_abnormal_response_to | 2.46464744 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.44706025 |
| 15 | MP0000609_abnormal_liver_physiology | 2.17198614 |
| 16 | MP0005058_abnormal_lysosome_morphology | 2.15720890 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.13147093 |
| 18 | MP0001819_abnormal_immune_cell | 2.12018944 |
| 19 | MP0008260_abnormal_autophagy | 2.10641213 |
| 20 | MP0003763_abnormal_thymus_physiology | 1.92349951 |
| 21 | MP0005083_abnormal_biliary_tract | 1.90328888 |
| 22 | MP0003436_decreased_susceptibility_to | 1.89884760 |
| 23 | MP0003172_abnormal_lysosome_physiology | 1.78112745 |
| 24 | MP0001666_abnormal_nutrient_absorption | 1.77535687 |
| 25 | MP0005670_abnormal_white_adipose | 1.70101487 |
| 26 | MP0004185_abnormal_adipocyte_glucose | 1.69893523 |
| 27 | MP0003828_pulmonary_edema | 1.65752113 |
| 28 | MP0005332_abnormal_amino_acid | 1.65608640 |
| 29 | MP0000716_abnormal_immune_system | 1.62128075 |
| 30 | MP0002118_abnormal_lipid_homeostasis | 1.58457655 |
| 31 | MP0000858_altered_metastatic_potential | 1.53925050 |
| 32 | MP0002998_abnormal_bone_remodeling | 1.51884723 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.47923529 |
| 34 | MP0005451_abnormal_body_composition | 1.43550775 |
| 35 | MP0004264_abnormal_extraembryonic_tissu | 1.42088027 |
| 36 | MP0003303_peritoneal_inflammation | 1.37206148 |
| 37 | MP0005310_abnormal_salivary_gland | 1.37179628 |
| 38 | MP0005076_abnormal_cell_differentiation | 1.34219241 |
| 39 | MP0001873_stomach_inflammation | 1.33397288 |
| 40 | MP0002429_abnormal_blood_cell | 1.30840784 |
| 41 | MP0009278_abnormal_bone_marrow | 1.30353432 |
| 42 | MP0004019_abnormal_vitamin_homeostasis | 1.28863465 |
| 43 | MP0000598_abnormal_liver_morphology | 1.24397195 |
| 44 | MP0008004_abnormal_stomach_pH | 1.24165586 |
| 45 | MP0003724_increased_susceptibility_to | 1.22881258 |
| 46 | MP0003448_altered_tumor_morphology | 1.19936686 |
| 47 | MP0004947_skin_inflammation | 1.19619778 |
| 48 | MP0003566_abnormal_cell_adhesion | 1.19287064 |
| 49 | MP0002138_abnormal_hepatobiliary_system | 1.18986068 |
| 50 | MP0002132_abnormal_respiratory_system | 1.18235112 |
| 51 | MP0005023_abnormal_wound_healing | 1.16636633 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.15810586 |
| 53 | MP0002332_abnormal_exercise_endurance | 1.14029532 |
| 54 | MP0003091_abnormal_cell_migration | 1.13294577 |
| 55 | MP0005666_abnormal_adipose_tissue | 1.13026584 |
| 56 | MP0003300_gastrointestinal_ulcer | 1.11995744 |
| 57 | MP0000703_abnormal_thymus_morphology | 1.11547597 |
| 58 | MP0001851_eye_inflammation | 1.11209930 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.10287318 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.10287318 |
| 61 | MP0010352_gastrointestinal_tract_polyps | 1.09227867 |
| 62 | MP0010155_abnormal_intestine_physiology | 1.09210383 |
| 63 | MP0005464_abnormal_platelet_physiology | 1.09045626 |
| 64 | MP0004808_abnormal_hematopoietic_stem | 1.08788481 |
| 65 | MP0002970_abnormal_white_adipose | 1.08560606 |
| 66 | MP0002971_abnormal_brown_adipose | 1.08008603 |
| 67 | MP0003183_abnormal_peptide_metabolism | 1.07222893 |
| 68 | MP0009115_abnormal_fat_cell | 1.05658927 |
| 69 | MP0005164_abnormal_response_to | 1.04421062 |
| 70 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03837849 |
| 71 | MP0009763_increased_sensitivity_to | 1.03313203 |
| 72 | MP0004883_abnormal_blood_vessel | 1.02987271 |
| 73 | MP0009643_abnormal_urine_homeostasis | 1.01810134 |
| 74 | MP0008469_abnormal_protein_level | 1.01380758 |
| 75 | MP0005390_skeleton_phenotype | 1.00262032 |
| 76 | MP0003453_abnormal_keratinocyte_physiol | 0.98366102 |
| 77 | MP0000490_abnormal_crypts_of | 0.96513338 |
| 78 | MP0002060_abnormal_skin_morphology | 0.96340547 |
| 79 | MP0000685_abnormal_immune_system | 0.96328875 |
| 80 | MP0008961_abnormal_basal_metabolism | 0.95911034 |
| 81 | MP0010368_abnormal_lymphatic_system | 0.93848836 |
| 82 | MP0002405_respiratory_system_inflammati | 0.92483463 |
| 83 | MP0002796_impaired_skin_barrier | 0.92175042 |
| 84 | MP0003195_calcinosis | 0.91829613 |
| 85 | MP0001845_abnormal_inflammatory_respons | 0.90381360 |
| 86 | MP0002933_joint_inflammation | 0.88294983 |
| 87 | MP0002254_reproductive_system_inflammat | 0.88218003 |
| 88 | MP0001533_abnormal_skeleton_physiology | 0.88213392 |
| 89 | MP0006082_CNS_inflammation | 0.87731263 |
| 90 | MP0000604_amyloidosis | 0.87538841 |
| 91 | MP0005334_abnormal_fat_pad | 0.86849008 |
| 92 | MP0003718_maternal_effect | 0.86664343 |
| 93 | MP0003075_altered_response_to | 0.86453585 |
| 94 | MP0004381_abnormal_hair_follicle | 0.86123037 |
| 95 | MP0003866_abnormal_defecation | 0.84673445 |
| 96 | MP0005375_adipose_tissue_phenotype | 0.84659931 |
| 97 | MP0003690_abnormal_glial_cell | 0.84387582 |
| 98 | MP0002419_abnormal_innate_immunity | 0.83421787 |
| 99 | MP0001800_abnormal_humoral_immune | 0.82951733 |
| 100 | MP0009764_decreased_sensitivity_to | 0.80669458 |
| 101 | MP0005166_decreased_susceptibility_to | 0.80587732 |
| 102 | MP0001243_abnormal_dermal_layer | 0.80171401 |
| 103 | MP0002166_altered_tumor_susceptibility | 0.78052582 |
| 104 | MP0000689_abnormal_spleen_morphology | 0.77281175 |
| 105 | MP0005025_abnormal_response_to | 0.77042962 |
| 106 | MP0004130_abnormal_muscle_cell | 0.76966373 |
| 107 | MP0003221_abnormal_cardiomyocyte_apopto | 0.75950885 |
| 108 | MP0001663_abnormal_digestive_system | 0.75644781 |
| 109 | MP0003186_abnormal_redox_activity | 0.75453336 |
| 110 | MP0000343_altered_response_to | 0.74939476 |
| 111 | MP0002877_abnormal_melanocyte_morpholog | 0.74667776 |
| 112 | MP0000249_abnormal_blood_vessel | 0.74359775 |
| 113 | MP0003795_abnormal_bone_structure | 0.74085198 |
| 114 | MP0003045_fibrosis | 0.74046791 |
| 115 | MP0002723_abnormal_immune_serum | 0.73999004 |
| 116 | MP0009785_altered_susceptibility_to | 0.73501672 |
| 117 | MP0010234_abnormal_vibrissa_follicle | 0.73235022 |
| 118 | MP0009642_abnormal_blood_homeostasis | 0.72991569 |
| 119 | MP0009333_abnormal_splenocyte_physiolog | 0.72339521 |
| 120 | MP0005387_immune_system_phenotype | 0.72099938 |
| 121 | MP0001790_abnormal_immune_system | 0.72099938 |
| 122 | MP0002396_abnormal_hematopoietic_system | 0.71608994 |
| 123 | MP0001835_abnormal_antigen_presentation | 0.71000422 |
| 124 | MP0004858_abnormal_nervous_system | 0.70664765 |
| 125 | MP0004510_myositis | 0.70297144 |
| 126 | MP0002277_abnormal_respiratory_mucosa | 0.70296364 |
| 127 | MP0000477_abnormal_intestine_morphology | 0.69932349 |
| 128 | MP0001853_heart_inflammation | 0.69514883 |
| 129 | MP0008874_decreased_physiological_sensi | 0.69174599 |
| 130 | MP0002722_abnormal_immune_system | 0.67700832 |
| 131 | MP0001542_abnormal_bone_strength | 0.67549274 |
| 132 | MP0000465_gastrointestinal_hemorrhage | 0.67523396 |
| 133 | MP0003011_delayed_dark_adaptation | 0.66761747 |
| 134 | MP0002019_abnormal_tumor_incidence | 0.66156347 |
| 135 | MP0008873_increased_physiological_sensi | 0.66151076 |
| 136 | MP0002452_abnormal_antigen_presenting | 0.65951504 |
| 137 | MP0003693_abnormal_embryo_hatching | 0.65644532 |
| 138 | MP0001764_abnormal_homeostasis | 0.65518966 |
| 139 | MP0005167_abnormal_blood-brain_barrier | 0.65300040 |
| 140 | MP0005395_other_phenotype | 0.64418177 |
| 141 | MP0005501_abnormal_skin_physiology | 0.64155324 |
| 142 | MP0002078_abnormal_glucose_homeostasis | 0.63777893 |
| 143 | MP0002398_abnormal_bone_marrow | 0.63192288 |
| 144 | MP0009765_abnormal_xenobiotic_induced | 0.62151140 |
| 145 | MP0003279_aneurysm | 0.59887240 |
| 146 | MP0001849_ear_inflammation | 0.57897948 |
| 147 | MP0006054_spinal_hemorrhage | 0.57183388 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.84514952 |
| 2 | Pustule (HP:0200039) | 5.54492369 |
| 3 | Xanthomatosis (HP:0000991) | 5.04642629 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.01224453 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.94519223 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.93319028 |
| 7 | Recurrent abscess formation (HP:0002722) | 4.88716229 |
| 8 | Orchitis (HP:0100796) | 4.83952333 |
| 9 | Myositis (HP:0100614) | 4.81136209 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.56498202 |
| 11 | Retrobulbar optic neuritis (HP:0100654) | 4.47541419 |
| 12 | Optic neuritis (HP:0100653) | 4.47541419 |
| 13 | Complement deficiency (HP:0004431) | 4.43140778 |
| 14 | Intrahepatic cholestasis (HP:0001406) | 4.40802640 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 4.13273908 |
| 16 | Prolonged partial thromboplastin time (HP:0003645) | 4.00867761 |
| 17 | Hypercholesterolemia (HP:0003124) | 3.90895662 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 3.90564273 |
| 19 | Hyperlipoproteinemia (HP:0010980) | 3.81305530 |
| 20 | Stomatitis (HP:0010280) | 3.73357499 |
| 21 | Increased IgE level (HP:0003212) | 3.67392554 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 3.65304539 |
| 23 | Abnormality of complement system (HP:0005339) | 3.64753972 |
| 24 | Hypolipoproteinemia (HP:0010981) | 3.59760138 |
| 25 | Myocardial infarction (HP:0001658) | 3.55800329 |
| 26 | Abnormality of the common coagulation pathway (HP:0010990) | 3.51583488 |
| 27 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.49249316 |
| 28 | Abnormality of glycolipid metabolism (HP:0010969) | 3.45123211 |
| 29 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.45123211 |
| 30 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.45123211 |
| 31 | Joint hemorrhage (HP:0005261) | 3.42866790 |
| 32 | Alopecia of scalp (HP:0002293) | 3.35270297 |
| 33 | Obstructive lung disease (HP:0006536) | 3.29913873 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 3.29913873 |
| 35 | Keratoconjunctivitis sicca (HP:0001097) | 3.29225060 |
| 36 | Meningitis (HP:0001287) | 3.21895283 |
| 37 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.21837776 |
| 38 | Gastrointestinal infarctions (HP:0005244) | 3.21789389 |
| 39 | Recurrent fungal infections (HP:0002841) | 3.19969992 |
| 40 | Recurrent skin infections (HP:0001581) | 3.14445991 |
| 41 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.11484121 |
| 42 | Vasculitis (HP:0002633) | 3.10130382 |
| 43 | Cellulitis (HP:0100658) | 3.05995139 |
| 44 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.04675755 |
| 45 | Gingivitis (HP:0000230) | 2.99492835 |
| 46 | Epidermoid cyst (HP:0200040) | 2.97751718 |
| 47 | Keratoconjunctivitis (HP:0001096) | 2.94841513 |
| 48 | Hyperammonemia (HP:0001987) | 2.92671163 |
| 49 | Hypoglycemic coma (HP:0001325) | 2.91350029 |
| 50 | Urticaria (HP:0001025) | 2.90138499 |
| 51 | Ketosis (HP:0001946) | 2.83281000 |
| 52 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.83143931 |
| 53 | Polycythemia (HP:0001901) | 2.83000868 |
| 54 | Increased cerebral lipofuscin (HP:0011813) | 2.73118396 |
| 55 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.72779054 |
| 56 | Hyperacusis (HP:0010780) | 2.71012487 |
| 57 | Loss of speech (HP:0002371) | 2.69063695 |
| 58 | Dysostosis multiplex (HP:0000943) | 2.67770868 |
| 59 | Encephalitis (HP:0002383) | 2.66401582 |
| 60 | Pulmonary infiltrates (HP:0002113) | 2.66312689 |
| 61 | Recurrent viral infections (HP:0004429) | 2.65528775 |
| 62 | Systemic lupus erythematosus (HP:0002725) | 2.63913773 |
| 63 | Abnormality of the intrinsic pathway (HP:0010989) | 2.63127924 |
| 64 | Gingival bleeding (HP:0000225) | 2.61356948 |
| 65 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.56568925 |
| 66 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.56120891 |
| 67 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.55466845 |
| 68 | Recurrent cutaneous fungal infections (HP:0011370) | 2.51924798 |
| 69 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.51924798 |
| 70 | Hemoptysis (HP:0002105) | 2.51752419 |
| 71 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.43668800 |
| 72 | Arterial thrombosis (HP:0004420) | 2.43085497 |
| 73 | Chest pain (HP:0100749) | 2.41423870 |
| 74 | Hypertriglyceridemia (HP:0002155) | 2.39448114 |
| 75 | Esophageal varix (HP:0002040) | 2.37986321 |
| 76 | Inflammation of the large intestine (HP:0002037) | 2.37852002 |
| 77 | Gastrointestinal inflammation (HP:0004386) | 2.37715487 |
| 78 | Gastrointestinal stroma tumor (HP:0100723) | 2.30470692 |
| 79 | Abnormality of iron homeostasis (HP:0011031) | 2.30088363 |
| 80 | Spontaneous abortion (HP:0005268) | 2.28414496 |
| 81 | Vacuolated lymphocytes (HP:0001922) | 2.27674047 |
| 82 | Fat malabsorption (HP:0002630) | 2.26781395 |
| 83 | Increased IgM level (HP:0003496) | 2.26374364 |
| 84 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.25125370 |
| 85 | Petechiae (HP:0000967) | 2.24695963 |
| 86 | Prolonged bleeding time (HP:0003010) | 2.24475026 |
| 87 | Abnormality of methionine metabolism (HP:0010901) | 2.24379133 |
| 88 | Menorrhagia (HP:0000132) | 2.23625026 |
| 89 | Abnormality of nucleobase metabolism (HP:0010932) | 2.23587678 |
| 90 | Slow saccadic eye movements (HP:0000514) | 2.23073500 |
| 91 | Episodic fever (HP:0001954) | 2.21681106 |
| 92 | Cholelithiasis (HP:0001081) | 2.21378405 |
| 93 | Reticulocytosis (HP:0001923) | 2.20607347 |
| 94 | Gangrene (HP:0100758) | 2.19161101 |
| 95 | Abnormality of the lower motor neuron (HP:0002366) | 2.18943505 |
| 96 | Osteomyelitis (HP:0002754) | 2.18239380 |
| 97 | Hyperglycinuria (HP:0003108) | 2.17305177 |
| 98 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.17232702 |
| 99 | Broad metatarsal (HP:0001783) | 2.16908285 |
| 100 | Anorexia (HP:0002039) | 2.16330845 |
| 101 | Mitral stenosis (HP:0001718) | 2.16231014 |
| 102 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.13408118 |
| 103 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.12208739 |
| 104 | Abnormality of glycine metabolism (HP:0010895) | 2.12208739 |
| 105 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.11847802 |
| 106 | Hypergammaglobulinemia (HP:0010702) | 2.11611140 |
| 107 | Peritonitis (HP:0002586) | 2.11530483 |
| 108 | Abnormal gallbladder physiology (HP:0012438) | 2.11262523 |
| 109 | Cholecystitis (HP:0001082) | 2.11262523 |
| 110 | Late onset (HP:0003584) | 2.10450816 |
| 111 | Ulnar bowing (HP:0003031) | 2.09508584 |
| 112 | T lymphocytopenia (HP:0005403) | 2.09446796 |
| 113 | Leukocytosis (HP:0001974) | 2.08814844 |
| 114 | Abnormal gallbladder morphology (HP:0012437) | 2.08542224 |
| 115 | Interstitial pulmonary disease (HP:0006530) | 2.08526752 |
| 116 | Abnormality of purine metabolism (HP:0004352) | 2.07321072 |
| 117 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.06634952 |
| 118 | Skin nodule (HP:0200036) | 2.04835668 |
| 119 | Glomerulopathy (HP:0100820) | 2.04771589 |
| 120 | Hyperglycinemia (HP:0002154) | 2.04429073 |
| 121 | Increased serum ferritin (HP:0003281) | 2.03766248 |
| 122 | Broad face (HP:0000283) | 2.02443588 |
| 123 | Abnormality of the pleura (HP:0002103) | 2.01238489 |
| 124 | Hypochromic microcytic anemia (HP:0004840) | 2.01222777 |
| 125 | Pulmonary embolism (HP:0002204) | 2.01096944 |
| 126 | Spontaneous hematomas (HP:0007420) | 2.00497438 |
| 127 | Purpura (HP:0000979) | 2.00081400 |
| 128 | Autoimmune thrombocytopenia (HP:0001973) | 1.99434073 |
| 129 | Abnormality of the peritoneum (HP:0002585) | 1.96567029 |
| 130 | Premature loss of primary teeth (HP:0006323) | 1.95985951 |
| 131 | Delayed CNS myelination (HP:0002188) | 1.95596950 |
| 132 | Abnormality of T cell number (HP:0011839) | 1.95451411 |
| 133 | Hemorrhage of the eye (HP:0011885) | 1.94673620 |
| 134 | Hypochromic anemia (HP:0001931) | 1.94665793 |
| 135 | Spastic diplegia (HP:0001264) | 1.94635881 |
| 136 | Disinhibition (HP:0000734) | 1.94549423 |
| 137 | Sepsis (HP:0100806) | 1.94410018 |
| 138 | Emphysema (HP:0002097) | 1.94393980 |
| 139 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.94103994 |
| 140 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.94103994 |
| 141 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.94103994 |
| 142 | Lymphopenia (HP:0001888) | 1.93956082 |
| 143 | Cerebral palsy (HP:0100021) | 1.91767947 |
| 144 | Abnormality of the endocardium (HP:0004306) | 1.91666052 |
| 145 | Eczematoid dermatitis (HP:0000976) | 1.91313828 |
| 146 | Hyperbilirubinemia (HP:0002904) | 1.91154633 |
| 147 | Abnormality of the nasal mucosa (HP:0000433) | 1.89925857 |
| 148 | Granulocytopenia (HP:0001913) | 1.89817831 |
| 149 | Hepatosplenomegaly (HP:0001433) | 1.89810272 |
| 150 | Abnormality of the pericardium (HP:0001697) | 1.88833450 |
| 151 | Cheilitis (HP:0100825) | 1.88710749 |
| 152 | Hepatocellular carcinoma (HP:0001402) | 1.88562605 |
| 153 | Increased mean platelet volume (HP:0011877) | 1.88126328 |
| 154 | Epistaxis (HP:0000421) | 1.87810097 |
| 155 | Asymmetric septal hypertrophy (HP:0001670) | 1.87520070 |
| 156 | Restrictive lung disease (HP:0002091) | 1.87383987 |
| 157 | Skin ulcer (HP:0200042) | 1.86459148 |
| 158 | Increased connective tissue (HP:0009025) | 1.85726427 |
| 159 | Hyperglycemia (HP:0003074) | 1.85607992 |
| 160 | Nasal polyposis (HP:0100582) | 1.85415884 |
| 161 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.85078598 |
| 162 | Flat acetabular roof (HP:0003180) | 1.84742415 |
| 163 | Glomerulonephritis (HP:0000099) | 1.84191475 |
| 164 | Mucopolysacchariduria (HP:0008155) | 1.83804713 |
| 165 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.83804713 |
| 166 | Ketoacidosis (HP:0001993) | 1.83132921 |
| 167 | Acne (HP:0001061) | 1.82290905 |
| 168 | Thrombophlebitis (HP:0004418) | 1.82264248 |
| 169 | Paralysis (HP:0003470) | 1.82032991 |
| 170 | Abnormal cartilage morphology (HP:0002763) | 1.81620181 |
| 171 | Abnormal platelet volume (HP:0011876) | 1.81132712 |
| 172 | Colitis (HP:0002583) | 1.78667555 |
| 173 | Malnutrition (HP:0004395) | 1.78450531 |
| 174 | Irritability (HP:0000737) | 1.77611660 |
| 175 | Turricephaly (HP:0000262) | 1.76502293 |
| 176 | Amyloidosis (HP:0011034) | 1.76007319 |
| 177 | Hand muscle atrophy (HP:0009130) | 1.75969397 |
| 178 | Upper limb amyotrophy (HP:0009129) | 1.75171752 |
| 179 | Distal upper limb amyotrophy (HP:0007149) | 1.75171752 |
| 180 | Abnormality of the Achilles tendon (HP:0005109) | 1.73097597 |
| 181 | Abnormal platelet function (HP:0011869) | 1.72626088 |
| 182 | Impaired platelet aggregation (HP:0003540) | 1.72626088 |
| 183 | Dicarboxylic aciduria (HP:0003215) | 1.72013178 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.56655577 |
| 2 | TRIB3 | 4.06636079 |
| 3 | RIPK4 | 3.58792005 |
| 4 | PRPF4B | 3.36405418 |
| 5 | IRAK4 | 2.85300418 |
| 6 | MAP3K10 | 2.76002324 |
| 7 | CDK12 | 2.60420552 |
| 8 | IRAK3 | 2.60130717 |
| 9 | TAOK3 | 2.58676887 |
| 10 | BLK | 2.50993579 |
| 11 | PKN2 | 2.49359046 |
| 12 | CAMK1D | 2.49074427 |
| 13 | SIK1 | 2.48932556 |
| 14 | EEF2K | 2.34200832 |
| 15 | MAP3K14 | 2.31057535 |
| 16 | TAOK1 | 2.21381655 |
| 17 | MAP4K1 | 2.17453020 |
| 18 | STK10 | 2.11927467 |
| 19 | FGFR4 | 1.97108396 |
| 20 | TAOK2 | 1.94803556 |
| 21 | BCKDK | 1.94306539 |
| 22 | SMG1 | 1.72300572 |
| 23 | MAP3K13 | 1.66205283 |
| 24 | GRK6 | 1.65900911 |
| 25 | RIPK1 | 1.63356261 |
| 26 | LATS1 | 1.60434607 |
| 27 | KDR | 1.59299368 |
| 28 | CAMK1G | 1.55566164 |
| 29 | FGR | 1.43978227 |
| 30 | TNK2 | 1.40080159 |
| 31 | ICK | 1.39484747 |
| 32 | CSK | 1.38486434 |
| 33 | TYK2 | 1.37723381 |
| 34 | TTN | 1.36885903 |
| 35 | FES | 1.36590895 |
| 36 | SIK2 | 1.35879036 |
| 37 | PTK6 | 1.35083766 |
| 38 | JAK3 | 1.31642459 |
| 39 | SIK3 | 1.29607983 |
| 40 | LRRK2 | 1.28698860 |
| 41 | MAP3K6 | 1.28595104 |
| 42 | IRAK2 | 1.28382620 |
| 43 | PIM1 | 1.23894855 |
| 44 | ERBB4 | 1.22536455 |
| 45 | TBK1 | 1.22266849 |
| 46 | FLT3 | 1.19257670 |
| 47 | BMX | 1.15396150 |
| 48 | KIT | 1.14806810 |
| 49 | EPHB1 | 1.14511919 |
| 50 | IRAK1 | 1.08485247 |
| 51 | TGFBR2 | 1.08465786 |
| 52 | SYK | 1.07306140 |
| 53 | PTK2 | 1.06411106 |
| 54 | MAPK11 | 1.06355165 |
| 55 | NME2 | 1.05081728 |
| 56 | CDC42BPA | 1.04228650 |
| 57 | TESK2 | 1.02928802 |
| 58 | LATS2 | 1.00655242 |
| 59 | GRK7 | 1.00239743 |
| 60 | ZAP70 | 1.00122431 |
| 61 | TXK | 0.98357532 |
| 62 | MAP2K3 | 0.95340832 |
| 63 | LYN | 0.91653752 |
| 64 | JAK2 | 0.89659326 |
| 65 | * MTOR | 0.87857503 |
| 66 | NEK2 | 0.87347305 |
| 67 | MAP3K11 | 0.86713055 |
| 68 | DYRK1B | 0.85180824 |
| 69 | PIK3CG | 0.83746696 |
| 70 | TYRO3 | 0.81367669 |
| 71 | CSF1R | 0.80461281 |
| 72 | TTK | 0.78954527 |
| 73 | LCK | 0.78490912 |
| 74 | CHUK | 0.78429535 |
| 75 | CDK4 | 0.77969357 |
| 76 | ITK | 0.76834488 |
| 77 | JAK1 | 0.76547494 |
| 78 | PDPK1 | 0.75517787 |
| 79 | STK3 | 0.74926963 |
| 80 | BMPR2 | 0.74692228 |
| 81 | MAPK7 | 0.74487871 |
| 82 | MARK3 | 0.72562265 |
| 83 | PDK1 | 0.72506958 |
| 84 | PRKD2 | 0.68573650 |
| 85 | MAPK12 | 0.66717102 |
| 86 | CDK9 | 0.66139823 |
| 87 | PRKG2 | 0.64889726 |
| 88 | CAMK4 | 0.64257781 |
| 89 | HIPK2 | 0.64065538 |
| 90 | PIK3CA | 0.63589068 |
| 91 | PDGFRA | 0.60677543 |
| 92 | RPS6KA4 | 0.60578001 |
| 93 | MAP3K5 | 0.59214105 |
| 94 | MAP3K8 | 0.58576575 |
| 95 | RPS6KC1 | 0.58532580 |
| 96 | RPS6KL1 | 0.58532580 |
| 97 | ALK | 0.58515121 |
| 98 | RAF1 | 0.58283330 |
| 99 | MAPKAPK3 | 0.58102240 |
| 100 | MAP3K3 | 0.57664856 |
| 101 | BTK | 0.57620342 |
| 102 | ARAF | 0.56822066 |
| 103 | CDK6 | 0.56152106 |
| 104 | MAP3K7 | 0.55254956 |
| 105 | EPHA2 | 0.54207564 |
| 106 | KSR2 | 0.53319848 |
| 107 | ABL2 | 0.52546414 |
| 108 | RPS6KB2 | 0.51237653 |
| 109 | PIM2 | 0.51220736 |
| 110 | PRKAA2 | 0.51015697 |
| 111 | MATK | 0.50575167 |
| 112 | RPS6KA1 | 0.49903953 |
| 113 | PRKAA1 | 0.49674906 |
| 114 | CDK7 | 0.49156576 |
| 115 | HCK | 0.48457701 |
| 116 | SGK3 | 0.48375832 |
| 117 | DDR2 | 0.47660250 |
| 118 | FGFR3 | 0.46573950 |
| 119 | YES1 | 0.45339158 |
| 120 | RPS6KA6 | 0.43029298 |
| 121 | MAPKAPK2 | 0.42673100 |
| 122 | MOS | 0.42583582 |
| 123 | MST1R | 0.41203744 |
| 124 | IKBKB | 0.41178971 |
| 125 | MAP3K2 | 0.41175346 |
| 126 | MAPK4 | 0.41157468 |
| 127 | PAK4 | 0.39016474 |
| 128 | MAP2K2 | 0.38827063 |
| 129 | EPHA3 | 0.38579005 |
| 130 | MARK2 | 0.38470354 |
| 131 | MAP3K1 | 0.38406474 |
| 132 | RPS6KA2 | 0.38091793 |
| 133 | KSR1 | 0.37857093 |
| 134 | MAP3K9 | 0.37088974 |
| 135 | AURKB | 0.37071009 |
| 136 | CHEK2 | 0.36494168 |
| 137 | IKBKE | 0.35949277 |
| 138 | BRAF | 0.34239938 |
| 139 | MAPK1 | 0.34065396 |
| 140 | EGFR | 0.34051253 |
| 141 | NEK1 | 0.33001472 |
| 142 | DAPK2 | 0.32433002 |
| 143 | TESK1 | 0.31802896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.73768558 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.99728565 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.99316463 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.89172646 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.87701092 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.60934603 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.60602720 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.53026280 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.46779558 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.35017012 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.23698867 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.21005850 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.10261556 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.08604487 |
| 15 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.07945717 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.04280920 |
| 17 | Allograft rejection_Homo sapiens_hsa05330 | 2.04275758 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.98265636 |
| 19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.98037062 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.97894196 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90348391 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.88739429 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.87050995 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.84451646 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.84192501 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.78486183 |
| 27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.75925050 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.73911411 |
| 29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.73309763 |
| 30 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.73255406 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.71972817 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.66096379 |
| 33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.62959124 |
| 34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.62123505 |
| 35 | Measles_Homo sapiens_hsa05162 | 1.59849455 |
| 36 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.59006566 |
| 37 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.55777713 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.55216379 |
| 39 | Lysine degradation_Homo sapiens_hsa00310 | 1.53111152 |
| 40 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.52082171 |
| 41 | Peroxisome_Homo sapiens_hsa04146 | 1.51913497 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.51906938 |
| 43 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.50193731 |
| 44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.48849456 |
| 45 | Viral myocarditis_Homo sapiens_hsa05416 | 1.43768464 |
| 46 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.42921266 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 1.40884348 |
| 48 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.40531564 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.40362078 |
| 50 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.36735889 |
| 51 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.36582723 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.36323196 |
| 53 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.36218750 |
| 54 | Hepatitis B_Homo sapiens_hsa05161 | 1.35871674 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.35741926 |
| 56 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.35343275 |
| 57 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.35217057 |
| 58 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.32974134 |
| 59 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.32615677 |
| 60 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.31712407 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.31211933 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 1.31202734 |
| 63 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.28175511 |
| 64 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.26017916 |
| 65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.25846640 |
| 66 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.25194934 |
| 67 | Asthma_Homo sapiens_hsa05310 | 1.24901416 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 1.24860326 |
| 69 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.24762217 |
| 70 | Salmonella infection_Homo sapiens_hsa05132 | 1.24101374 |
| 71 | Bile secretion_Homo sapiens_hsa04976 | 1.23596256 |
| 72 | Carbon metabolism_Homo sapiens_hsa01200 | 1.22445692 |
| 73 | Lysosome_Homo sapiens_hsa04142 | 1.21900202 |
| 74 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.18243991 |
| 75 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.17943397 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.13121700 |
| 77 | Phagosome_Homo sapiens_hsa04145 | 1.12291609 |
| 78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.09306055 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.09175351 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.07338493 |
| 81 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06066814 |
| 82 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.05211117 |
| 83 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.05033884 |
| 84 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.04540155 |
| 85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03090047 |
| 86 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.02709250 |
| 87 | Retinol metabolism_Homo sapiens_hsa00830 | 1.00774451 |
| 88 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97192337 |
| 89 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.96311974 |
| 90 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.95667401 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95013052 |
| 92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.93894274 |
| 93 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93280291 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92892699 |
| 95 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.91718848 |
| 96 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91058035 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90007164 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.89568293 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.89389063 |
| 100 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86513807 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.84151010 |
| 102 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82917881 |
| 103 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.80943926 |
| 104 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79869363 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77558907 |
| 106 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.75842749 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74714469 |
| 108 | HTLV-I infection_Homo sapiens_hsa05166 | 0.73927806 |
| 109 | Platelet activation_Homo sapiens_hsa04611 | 0.70970173 |
| 110 | Endocytosis_Homo sapiens_hsa04144 | 0.69303199 |
| 111 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.68754029 |
| 112 | Endometrial cancer_Homo sapiens_hsa05213 | 0.66485362 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66384059 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65707974 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62930122 |
| 116 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.62928146 |
| 117 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58222501 |
| 118 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54870611 |
| 119 | Prostate cancer_Homo sapiens_hsa05215 | 0.54206555 |
| 120 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53999135 |
| 121 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.53212802 |
| 122 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52641562 |
| 123 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51520895 |
| 124 | Bladder cancer_Homo sapiens_hsa05219 | 0.51001628 |
| 125 | Galactose metabolism_Homo sapiens_hsa00052 | 0.49212969 |
| 126 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48916839 |
| 127 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.48890047 |
| 128 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48883840 |
| 129 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48573723 |
| 130 | Colorectal cancer_Homo sapiens_hsa05210 | 0.47675440 |
| 131 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47356801 |
| 132 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46509802 |
| 133 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45234651 |
| 134 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45213504 |
| 135 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.43752215 |
| 136 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41633455 |
| 137 | Glioma_Homo sapiens_hsa05214 | 0.41522505 |
| 138 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.40500724 |
| 139 | Leishmaniasis_Homo sapiens_hsa05140 | 0.39797921 |
| 140 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38961621 |
| 141 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.38009906 |
| 142 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.37867625 |
| 143 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.36660115 |
| 144 | Prion diseases_Homo sapiens_hsa05020 | 0.36622838 |
| 145 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.36489270 |
| 146 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36265084 |
| 147 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.35357061 |
| 148 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.33785812 |
| 149 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.32072708 |
| 150 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.31407820 |
| 151 | Apoptosis_Homo sapiens_hsa04210 | 0.30087752 |
| 152 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.29913365 |
| 153 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.29528676 |
| 154 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29182298 |
| 155 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28504344 |
| 156 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.27995069 |
| 157 | Legionellosis_Homo sapiens_hsa05134 | 0.27895753 |
| 158 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.25022402 |
| 159 | Shigellosis_Homo sapiens_hsa05131 | 0.23775596 |
| 160 | Circadian rhythm_Homo sapiens_hsa04710 | 0.23522929 |
| 161 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.22985409 |
| 162 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.22628648 |
| 163 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22616406 |
| 164 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.22060258 |
| 165 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.22048330 |
| 166 | Amoebiasis_Homo sapiens_hsa05146 | 0.20883222 |
| 167 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.19118673 |
| 168 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.18689352 |
| 169 | Other glycan degradation_Homo sapiens_hsa00511 | 0.18206384 |
| 170 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.17893708 |
| 171 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.17300375 |

